Sheng Han

The impacts of government reimbursement negotiation on targeted anticancer medication price, volume and spending in China

Yichen Zhang, Haishaerjiang Wushouer, Sheng Han et al. · BMJ Global Health · 2021 · 66 citations · Full text

Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry

Shinya Goto, Pantep Angchaisuksiri, Jean‐Pierre Bassand et al. · Journal of the American Heart Association · 2019 · 54 citations · Full text

Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China

Yichen Zhang, Yuxuan Wei, Huangqianyu Li et al. · PharmacoEconomics · 2022 · 39 citations · Full text

Effectiveness of hierarchical medical system policy: an interrupted time series analysis of a pilot scheme in China

Huajie Hu, Ruilin Wang, Huangqianyu Li et al. · Health Policy and Planning · 2023 · 28 citations · Full text

Health Administration, Family Medicine, Comparative Health Systems +27

Reduced medical costs and hospital days when using oral arsenic plus ATRA as the first-line treatment of acute promyelocytic leukemia

Hao Jiang, Gong‐Wen Liang, Xiao‐Jun Huang et al. · Leukemia Research · 2015 · 27 citations

Hematological Malignancy, Oncology, Mixed-phenotype Acute Leukemia +7